{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:10:46Z","timestamp":1770991846728,"version":"3.50.1"},"reference-count":39,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T00:00:00Z","timestamp":1072051200000},"content-version":"vor","delay-in-days":477,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> The aim of this work was to study and compare the tocolytic effects of rofecoxib with indomethacin, ritodrine, nicardipine and atosiban. We also studied the combination of rofecoxib with each agent.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold>  <jats:italic>In vitro<\/jats:italic> animal experimental study.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Non\u2010selective cyclo\u2010oxygenase (COX) inhibitors have potent tocolytic effect. However, they also have major fetal side effects that seem to be due to COX\u20101 inhibition. A specific COX\u20102 inhibitor could be a potent tocolytic agent with less fetal toxicity.<\/jats:p><jats:p><jats:bold>Sample\n\t\t\t\t\t<\/jats:bold> Myometrial strips from pregnant Wistar rats at 18 days of gestation.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Isometric tension was recorded from 112 pregnant rat myometrial strips <jats:italic>in vitro<\/jats:italic>. Strips were exposed to increase molar concentration of one drug or combination.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Contractile activity was assessed by calculating the area under the curve, to obtain a dose\u2013response curve of each drug. <jats:styled-content>EC<jats:sub>50<\/jats:sub><\/jats:styled-content> and mean maximal inhibiting concentration were compared using ANOVA. Chemical interaction was defined for each combination.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> The <jats:italic>in vitro<\/jats:italic> tocolytic effect of rofecoxib was demonstrated. Contractile activity stopped at a concentration of <jats:styled-content>1.6 \u00d7 10<jats:sup>\u22127<\/jats:sup><\/jats:styled-content> M. Effective concentrations were 1000 times less than for indomethacin and significantly lower than ritodrine and atosiban. Rofecoxib combined with ritodrine had a synergic effect. Other combinations only had an additive effect.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Rofecoxib has a potent tocolytic effect <jats:italic>in vitro<\/jats:italic>. The high specificity and low effective concentrations of COX\u20102 may result in low fetal toxicity. Animal fetal side effects need to be explored.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2002.01518.x","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T15:31:23Z","timestamp":1072107083000},"page":"983-988","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["<i>In vitro<\/i> study of tocolytic effect of rofecoxib, a specific cyclo\u2010oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents"],"prefix":"10.1111","volume":"109","author":[{"given":"Muriel","family":"Doret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Mellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Benchaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Michel","family":"Piacenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Charles","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/367215a0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00363-0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.7.913"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1043"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90087-X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10205.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/5.9.880"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.2.517"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(00)70226-2"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/plac.1999.0438"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90376-T"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199911001-00043"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.111718"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62229-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1998.tb06905.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-5576(99)00034-9"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.106584"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12154-2"},{"key":"e_1_2_6_20_2","first-page":"551","article-title":"Rofecoxib [Vioxx, MK\u20100966; 4\u2010(4\u2032\u2010methylsulfonylphenyl)\u20103\u2010phenyl\u20102\u2010(5H)\u2010furanone]: a potent and orally active cyclooxygenase\u20102 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan CC","year":"1999","journal-title":"Eur J Pharmacol Exp Ther"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702211"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01522-8"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70035-3"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1999.276.3.R913"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2000.278.6.R1496"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1993.tb15143.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.9.3468"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.5.1705"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70157-2"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.3.894"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050736"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-0997(1997)5:2<98::AID-IDOG3>3.0.CO;2-3"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/107155769800500403"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1530\/ror.0.0030196"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/277032a0"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199404000-00024"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90415-4"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(83)90026-7"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600116"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(96)00047-2"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2002.01518.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2002.01518.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:39:16Z","timestamp":1697567956000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2002.01518.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1111\/j.1471-0528.2002.01518.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2002.01518.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"2003-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}